Hirsch Susan B 4
4 · AGENUS INC · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) Director Susan B. Hirsch Receives Award
What Happened
- Susan B. Hirsch, a director of Agenus Inc. (AGEN), was granted a derivative award covering 105,000 shares on 2026-04-24. The Form 4 reports an acquisition price of $0.00 and a reported value of $0, consistent with an option/award rather than a cash purchase or sale.
Key Details
- Transaction date: 2026-04-24 (reported on Form 4 filed 2026-04-28). Filing appears timely (filed within the SEC’s 2-business-day window).
- Security/amount: 105,000 shares reported as a derivative award; acquisition price listed as $0.00.
- Shares owned after transaction: not specified in the provided filing data.
- Footnote: Award made under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan; the option vests on the one-year anniversary of the grant date.
Context
- This was an option/award grant (derivative), not an open-market purchase or sale. The award does not represent immediately tradable common shares until any applicable vesting and exercise requirements are met.
- Such awards are common for directors as compensation; they are informational but do not by themselves indicate immediate buying or selling intent.
Insider Transaction Report
Form 4
AGENUS INCAGEN
Hirsch Susan B
Director
Transactions
- Award
Stock Option
[F1]2026-04-24+105,000→ 105,000 totalExercise: $3.90Exp: 2036-04-24→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.
Signature
/s/Austin Charette, as Attorney-in-Fact for Susan Hirsch|2026-04-28